STAAR Surgical to Present at the Stephens Fall Investment Conference in New York
MONROVIA, Calif., Nov. 10, 2010 /PRNewswire/ — STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the Stephens Fall Investment Conference at The New York Palace Hotel on Wednesday, November 17, 2010 at 11:00 a.m. Eastern Time.
Barry G. Caldwell, President and CEO, will review the company’s business strategy and recent corporate developments. Hans Blickensdoerfer, President of EMEA for STAAR, will also join Mr. Caldwell at the conference. STAAR will offer a live video webcast of its presentation on the Company’s website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 30 days, also at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” A lens used in refractive surgery as an alternative to LASIK is called an Implantable CollamerÃ‚® Lens or “ICL.” Over 195,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company’s website at www.staar.com or call 626-303-7902.
CONTACT: Investors Media EVC Group EVC Group Douglas Sherk, 415-896-6820 Chris Gale Jenifer Kirtland, 415-896-2005 646-201-5431
SOURCE STAAR Surgical Company